Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Bronstein, Gewirtz & Grossman LLC Urges Atara Biotherapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC has announced that a class action lawsuit has been filed against Atara Biotherapeutics, Inc. (NASDAQ: ATRA) and some of its officers. The lawsuit seeks to recover damages for investors who purchased Atara securities between May 20, 2024, and January 9, 2026, alleging that defendants made false and/or misleading statements regarding manufacturing issues and the likelihood of FDA approval for tabelecleucel. Investors are encouraged to join the case, with a lead plaintiff deadline of May 22, 2026.